Zydus Lifesciences Reports Strong Financial Growth Amid Score Adjustment in March 2025 Results
Zydus Lifesciences has announced its financial results for the quarter ending March 2025, showcasing stable performance. Key metrics include a Profit After Tax of Rs 2,358.67 crore, a year-on-year growth of 20.80%, and net sales of Rs 6,527.90 crore, the highest in five quarters.
Zydus Lifesciences, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending March 2025. The results indicate a stable financial performance during this period. However, there has been an adjustment in its evaluation, with the score reflecting a shift from 9 to 5 over the past three months.The financial data reveals several noteworthy trends. The Profit After Tax (PAT) for the latest six months stands at Rs 2,358.67 crore, showcasing a year-on-year growth of 20.80%. This positive trajectory in PAT suggests a favorable near-term outlook. Additionally, net sales reached Rs 6,527.90 crore, marking the highest figure in the last five quarters, indicating a robust sales performance. The operating profit (PBDIT) also reached a peak of Rs 2,125.50 crore in the same timeframe, further supporting the positive near-term trends. Furthermore, the Profit Before Tax (PBT), excluding other income, recorded a year-on-year growth of 30.53%, amounting to Rs 1,811.00 crore.
Overall, Zydus Lifesciences' recent financial results highlight significant growth in key metrics, despite the noted revision in its score.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
